Evidence map›Paper›PMID 28485318›Full record

ArticleChinese medical journal2017

A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China.

Jing Wang, Zhi-Yong Peng, Wen-Hai Zhou, Bo Hu, Xin Rao, Jian-Guo Li

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Chinese medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04217915 (A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04217915 unknown statusnot on this mapstarted 2021, after this paper: background citation

A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China

TypeobservationalSponsorChina Medical University, ChinaRan2021 to 2021Enrolled800ConditionsDelirium on Emergence, Analgesia, Separation
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Agitation is a Common Barrier to Recovery of ICU Patients.Journal of intensive care medicine · 2023
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jing WangDepartment of Intensive Care Unit, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Zhi-Yong PengDepartment of Intensive Care Unit, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Wen-Hai ZhouDepartment of Clinical Medicine, City College, Wuhan university of Science and Technology, Wuhan, Hubei 430083, China.
Bo HuDepartment of Intensive Care Unit, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Xin RaoDepartment of Intensive Care Unit, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Jian-Guo LiDepartment of Intensive Care Unit, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Zhongnan Hospital of Wuhan University · CNWuhan University · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe management of pain, agitation, and delirium (PAD) in Intensive Care Unit (ICU) is beneficial for patients and makes it widely applied in clinical practice. Previous studies showed that the clinical practice of PAD in ICU was improving; yet relatively little information is available in China. This study aimed to investigate the practice of PAD in ICUs in China.

methodsA multicenter, nationwide survey was conducted using a clinician-directed questionnaire from September 19 to December 18, 2016. The questionnaire focused on the assessment and management of PAD by the clinicians in ICUs. The practice of PAD was compared among the four regions of China (North, Southeast, Northwest, and Southwest). The data were expressed as percentage and frequency. The Chi-square test, Fisher's exact test, and line-row Chi-square test were used.

resultsOf the 1011 valid questionnaire forms, the response rate was 80.37%. The clinicians came from 704 hospitals across 158 cities of China. The rate of PAD assessment was 75.77%, 90.21%, and 66.77%, respectively. The rates of PAD scores were 45.8%, 68.94%, and 34.03%, respectively. The visual analog scale, Richmond agitation-sedation scale, and confusion assessment method for the ICU were the first choices of scales for PAD assessment. Fentanyl, midazolam, and dexmedetomidine were the first choices of agents for analgesic, sedation, and delirium treatment. While choosing analgesics and sedatives, the clinicians put the pharmacological characteristics of drugs in the first place (66.07% and 76.36%). Daily interruption for sedation was carried out by 67.26% clinicians. Most of the clinicians (87.24%) used analgesics while using sedatives. Of the 738 (73%) clinicians titrating the sedatives on the basis of the proposed target sedation level, 268 (26.61%) clinicians just depended on their clinical experience. Totally, 519 (51.34%) clinicians never used other nondrug strategies for PAD. The working time of clinicians was an important factor in the management of analgesia and sedation rather than their titles and educational background. The ratios of pain score and sedation score in the Southwest China were the highest and the North China were the lowest. The ratios of delirium assessment and score were the same in the four regions of China. Moreover, the first choices of scales for PAD in the four regions were the same. However, the top three choices of agents in PAD treatment in the four regions were not the same.

conclusionsThe practice of PAD in China follows the international guidelines; however, the pain assessment should be improved. The PAD practice is a little different across the four regions of China; however, the trend is consistent.

trial registrationThe study is registered at http://www.clinicaltrials.gov (No. ChiCTR-OOC-16009014, www.chictr. org.cn/index.aspx.).

Indexed as

DeliriumDexmedetomidineFentanylHaloperidolHumansHypnotics and SedativesIntensive Care UnitsMidazolamPainPain ManagementPain MeasurementSurveys and QuestionnairesDexmedetomidineFentanylHaloperidolHypnotics and SedativesMidazolam

Identifiers

PMID28485318
PMCPMC5443024
OpenAlexW2612197598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.